Evidence map›Paper›PMID 42091689›Full record

SynthesisScientific reports2026

Postoperative radiotherapy versus postoperative radiochemotherapy after surgery of salivary gland cancer: a systematic review and meta-analysis.

Anja Wilhelmy, Peter Schlattmann, Orlando Guntinas-Lichius

Abstract readSystematic ReviewMeta-AnalysisComparative Study
In one paragraph

Synthesis in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Anja WilhelmyDepartment of Otorhinolaryngology, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany.
Peter SchlattmannDepartment of Medical Statistics, Computer Sciences and Data Sciences, Jena University Hospital, 07747, Jena, Germany.
Orlando Guntinas-LichiusDepartment of Otorhinolaryngology, Jena University Hospital, Am Klinikum 1, 07747, Jena, Germany. orlando.guntinas@med.uni-jena.de.ORCID 0000-0001-9671-0784

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

There is a lack of prospective clinical trials on the therapy of salivary gland cancer (SGC) due the rarity and large variety of histological subtypes. This study aimed to compare overall survival (OS) after primary surgery of SGC followed by postoperative radiotherapy (PORT) versus radiochemotherapy (PORCT) in curative intent. A systematic review and meta-analysis were performed on studies reporting OS after the two postoperative therapy modalities using hazard ratios (HRs) or allowing to calculate the HRs from the data. These studies were identified from PubMed, Web of Science, and Cochrane Library databases until October 2024. Pooled HR with 95% confidence interval (CI) is reported with random-effects or fixed-effects models. The search yielded 1,074 publications, of which 11 retrospective clinical studies with 26,612 adult patients could be included. None of the studies found a statistically significant difference between PORT and PORCT. Likewise, this meta-analysis revealed no statistically significant difference between PORT and PORCT. The pooled HR based on a common effect model was 1.065 (CI: 0.998-1.137) with low between study heterogeneity (I²=24.1%) and heterogeneity variance τ

Indexed as

ChemoradiotherapySalivary Gland NeoplasmsHumansAdjuvant therapyChemotherapyOverall survivalParotid gland cancerSalivary glandsSubmandibular gland cancerToxicity

Identifiers

PMID42091689
PMCPMC13149990

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.